PA Launches Prescription Drug Monitoring Program
Pennsylvania’s Department of Health has launched its much-anticipated prescription drug monitoring program.
Previously operated by the state’s office of the attorney general but assigned to the state’s Health Department through 2014 legislation, the program requires those authorized to prescribe controlled substance prescription drugs to collect and submit information to the PDMP each time they do so within 72 hours. That information is then stored in a database that is available to health care professionals to help them identify patients who may have problems with controlled substances or may even be going from provider to provider to gain additional prescriptions.
The state Health Department has created a web site for the program that includes FAQs about how the PDMP works for those who prescribe and dispense controlled substances. Visit that web site here.
The centers are funded in part by state behavioral health funds, in part by state Medicaid funds, and in part by federal Medicaid matching funds.
The uninsured rate in the U.S., 20 percent before the Affordable Care Act took effect, is now 13 percent.
The report, prepared by the organization Catalyst for Payment Reform, seeks to
HealthChoices, Pennsylvania’s Medicaid managed care program, seeks to purchase 7.5 percent of Medicaid services through value-based purchasing arrangements in calendar year 2017, 15 percent in 2018, and 30 percent in 2019. The Hospital Quality Incentive Program seeks to facilitate achieving these goals.
In making these recommendations, CMS seeks to make greater use of managed long-term services and supports and home- and community-based services when serving individuals who might otherwise need costly nursing home care.
